Overview

Breast cancer is the most commonly occurring cancer among women in Singapore.

Each year, over 1,000 women are diagnosed with breast cancer, and over 400 die from the disease.* 1 in 13 women will get breast cancer in their lifetime.

Breast cancer usually originates from the cells lining the milk ducts and glands. When breast cancer is detected at this non-invasive or in-situ stage, treatment is easier and patients have a higher chance of recovery.

However, when cancer cells invade the surrounding tissue, known as the stroma, it can gain entry into the circulatory and lymphatic system, and hence, to other organs in the body, through the blood and lymphatic vessels found in the stroma. When these cancer cells reach a new site, they may form a metastatic tumour. The organs most commonly affected by this are the lungs, bones, and liver.

Risk Factors

Research has uncovered many risk factors associated with breast cancer, which can be reduced to prevent its occurrence. These risk factors are affected by:

1. Age and Sex
The risk of breast cancer increases with age. Most women who are diagnosed to have breast cancer are older than 40 years old. However, younger women may also be affected.

Breast cancer can also affect men but the risk is much lower as compared to women. However, when breast cancer is diagnosed in men, it is often at an advanced stage because of the small size of the male breast.

2. Family History
Certain genes have been identified and may be associated with the occurring of breast cancer, two of which are BRCA1 and BRCA2. A woman’s lifetime risk of developing breast cancer is greatly increased if she inherits an abnormal form of BRCA1 or BRCA2.

Woman with a first degree relative (i.e. mother, sister, or daughter) who has breast cancer is twice as likely to get breast cancer themselves, as compared to women without a family history of breast cancer. It is recommended woman with such a family history is to start breast cancer screening 10 years before the age of your relative’s diagnosis.

The likelihood of a woman in Singapore developing breast cancer in her lifetime is about 5%. However, those with a family history of breast cancer will have twice the risk compared with women without a family history.

3. Reproductive History
Certain aspects of a woman's reproductive history can increase her risk of breast cancer. These include:

• Not having children or having the first child after the age of 35
• Onset of menses before the age of 11
• Cessation of menses after the age of 55

These risk factors are associated with an early and prolonged exposure to oestrogen. To reduce risk, young girls below the age of 11 should be encouraged to exercise more as physical activity can delay the onset of menses and suppress the secretion of oestrogen. Breast-feeding, when carried out for more than a year, can also lower exposure to oestrogen and reduce a woman's risk of breast cancer.

4. Diet
Excessive consumption of red meat, animal fat, and alcohol may increase a woman's risk of breast cancer. Women are encouraged to limit the intake of saturated animal fats and increase the intake of fruits and vegetables to reduce the risk of developing cancer. Besides, it is best not to drink alcohol.

Other nutrients that alter a woman's risk of breast cancer include:

• Soy products in bean curd and soya bean juice could reduce a woman's risk of breast cancer
• Omega 3 oil from fish could reduce a woman's risk from breast cancer
• Other nutrients that protect against breast cancer include Vitamin A, Selenium, and Vitamin C and E

5. Body Weight and Physical Activity
Weight gain, especially in post-menopausal women, is associated with an increased risk of breast cancer. This may be due to the combination of high calories and fat intake as well as a lack of exercise. Physical exercise reduces a woman's risk of breast cancer by lowering her body's level of oestrogen.

Women should engage in regular physical activities as well as moderate calories and fat intake to avoid weight gain.

6. Intake of Hormones
There are 2 groups of women whose intake of oestrogen and/or progesterone supplements may increase the risk of breast cancer.

• Post-menopausal women who are long term or current users of Hormone Replacement Therapy (HRT) have a 30% increased risk of breast cancer. This risk disappears after three to five years of stopping HRT. Women should engage in close discussion with their doctor(s) before making a decision.
• Young girls who consume oral contraceptive pills between the ages of 10-15

7. Previous Abnormal Breast Biopsy
A few types of breast biopsy results may be indicative of an increased risk of breast cancer. Women whose biopsies indicate atypical ductal hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in-situ should undergo regular breast screening.

Women with previous instances of breast cancer are also at an increased risk of developing cancer in the same or opposite breast and should seek regular screening.

Doctors can now provide a fairly good estimate of a woman's risk of breast cancer by tracing a detailed family, social, and medical history.

Women who are at high risk of breast cancer can take action by:
• starting breast screening at an earlier age
• altering lifestyle and diet to reduce risk
• taking Tamoxifen, an important anti-cancer drug, which can significantly reduce the risk of breast cancer
• undergoing preventive prophylactic mastectomies. Women at high-risk who underwent bilateral mastectomies had a 90% reduction of risk. However, given the extensive nature of the surgery involved, women are advised to carefully consider their options. Despite the above list of risk factors, the exact cause of breast cancer remains unknown. About 50 per cent of breast cancer patients have no identifiable risk factors. 

{slider Signs and Symptoms}

Early Detection

Diagnosis

Diagnosis of breast cancer is based on:

• Clinical examination
• Mammography
• Ultrasound scan of the breast

To confirm the diagnosis, a breast biopsy is performed to remove a piece of tissue for examination under a microscope.

Common biopsy techniques include:

• Fine Needle Aspiration (FNA)
• Core Needle Biopsy
• Excision Biopsy
• Sentinel Lymph Node Biopsy (SLNB)

Treatment

Treatment broadly consists of two parts:

Locoregional treatment, which pairs surgery with radiotherapy to treat cancer cells in the breast and armpit lymph nodes

Mastectomy and Lumpectomy

The two surgical techniques used to treat breast cancer are mastectomy and lumpectomy:

A mastectomy entails the removal of the whole breast, including the nipple.

A lumpectomy entails the removal of a tumour along with a margin of normal breast tissue. This leaves the rest of the breast untouched. After a lumpectomy, radiotherapy is given to the breast for 6 weeks. This treatment is safe and has a low recurrence rate. Breast cancer patients who are suitable for lumpectomy and radiotherapy have:

• Tumours situated away from the nipple
• Tumours less than 2-3 cm in diameter
• Breasts of a suitable size

Breast cancer patients are not suitable for a lumpectomy if they:

• Are under the age of 30 due to a high recurrence rate
• Are pregnant
• Have connective tissue disease
• Have 2 or more tumours within the same breast

Armpit Surgery

Armpit surgery is required to remove the axillary lymph nodes for diagnostic and therapeutic purposes. Knowing whether cancer has entered the axillary lymph nodes is important in determining the stage of breast cancer. Removal of the axillary lymph nodes also prevents the recurrence of cancer in this area. Some breast cancer patients may experience temporary shoulder stiffness and arm swelling after this procedure.

Sentinel Lymph Node Biopsy (SLN Biopsy)

1 or 2 lymph nodes act as a gateway to the axilla and will be the first to be affected should cancer enter this area of the body. By identifying and biopsying these sentinel lymph nodes, it can be determined whether the rest of the axillary lymph nodes are affected by cancer.

SLN biopsy is a viable treatment option for patients with:

• Small tumours
• Non-palpable nodes in the axilla

SLN biopsy is not recommended for:

• Patients with large tumours and palpable nodes, who should undergo an axillary dissection
• Patients with non-invasive tumours, for whom no axillary surgery is required

Post-Mastectomy Breast Reconstruction

Following a mastectomy, breast reconstruction can be carried out using a variety of techniques. The following considerations may be important to note:

• Timing of Reconstruction

• Cost and Complications
  The breast can be reconstructed using an artificial implant (usually made of silicon) or a skin-muscle flap from the patient's own body. An artificial implant is quicker and cheaper to undertake but some women may be averse to the presence of a foreign object in their body.

  Extracting a skin-muscle flap from the patient is a natural method for breast reconstruction but is longer and costlier to undertake. This method may also lead to complications surrounding the area where the skin-muscle is taken.

• Cancer Recurrence
  An artificial implant or a reconstructed breast has not been found to interfere with the detection of cancer recurrence or to increase the risk of cancer recurrence.

Radiotherapy

Radiotherapy utilises radiation to treat breast cancer. Radiotherapy is recommended for the local treatment of breasts following a lumpectomy. It is given over 6 weeks during daily outpatient treatment sessions. Side effects are usually tolerable and mainly confined to the treatment area. Radiotherapy is also recommended for women after mastectomy whose risk of local recurrence is high and whose lymph nodes and tumours are more than 4cm wide.

Systemic treatment utilises chemotherapy or hormonal drugs such as Tamoxifen to eliminate clumps of cancer cells that may be circulating in a woman's body. The type of treatment varies depending on need and appropriate treatment to be adopted.

Risk Assessment

Based on microscopic analysis of biopsies or breast cancer cells, women may be divided into low or high risk groups. Women in the low-risk group may be treated with Tamoxifen while women in the high-risk group are offered systemic treatment. There are 3 main forms of systemic treatment: 

A. Cytotoxic Chemotherapy
This involves the administration of toxic drugs which are harmful to both cancer cells and healthy cells. Given their toxicity, the drugs are administered at controlled dosages over a period of time to limit their toxicity while eliminating cancer cells.

There are 3 main regimes, each consisting of a combination of cytotoxic drugs. Depending on the condition and needs of the patient, the most suitable regime is selected and administered at 3 weekly intervals over 4 to 6 months.

The following list of short-term side effects resulting from chemotherapy may be severe but are usually tolerable and temporary.

• Low total white cell count (Less than 2000/mm3)
• Fever
• Infection
• Nausea
• Diarrhoea
• Hair loss
• Low platelet count (Less than 50,000/mm3)
• Blood clots in veins
• Cystitis
• Weight gain (More than 10%)

Although these are significant side effects associated with cytotoxic chemotherapy, the mortality rate resulting from chemotherapy is low. Nevertheless, in very sick patients, death may result from overwhelming infection or the formation of blood clots in veins.

3 major long-term side effects associated with chemotherapy have been identified:

• Premature menopause – A woman in her forties has a 50 per cent chance of experiencing premature menopause if she undergoes chemotherapy. The effects of menopause are more severe in younger women, varying from hot flushes, palpitations, and dry skin to more debilitating conditions such as osteoporosis and increased risk of cardiovascular disease.
• Cardiac toxicity – Adriamycin (or Doxorubicin) is a common drug component of chemotherapy that can cause heart failure. However, the probability of experiencing this side effect is low and can be decreased by:
  1. Assessing cardiac function
  2. Limiting the dose administered
  3. Calibrating the method of drug administration
• Risk of a second cancer – Rare instances of chemotherapy-induced leukaemia have been recorded.

B. Hormonal Manipulation
This entails altering or stopping the secretion of oestrogen in the patient's body as a means of treating breast cancer through the use of Tamoxifen. It is taken orally once a day and causes few side effects. It is effective for:

• Women at high risk of breast cancer and is taken as a preventive drug.
• Women whose breast cancer is oestrogen receptor positive (ER+) and is at low risk of recurrence. Tamoxifen is given as the sole systemic drug.
• Women whose breast cancer is ER+ and is at high risk of recurrence. Tamoxipfen is combined with chemotherapy or other measures of hormonal manipulation.

C. Ovarian Ablation
This refers to methods to stop the secretion of oestrogen in a woman's body in order to reduce the stimulation of cancer cells and hence reduce the chance of cancer recurrence. This method applies only to pre-menopausal women and leads to premature menopause. Ovarian ablation can be achieved by surgical or non-surgical methods:

• Surgical Oophorectomy - Surgery is undertaken to permanently remove the ovaries. This method is now seldom used.
• Radiation Castration - Radiotherapy is given to patients over a 2 week period to permanently disable the ovaries from secreting oestrogen. This is a quick and relatively painless method.
• Ovarian Suppression - The secretion of oestrogen is controlled by the pituitary gland. Drugs can be prescribed to temporarily suppress oestrogen secretion. Ovarian function usually recovers once the drug is stopped. This is a relatively expensive method.

Support Groups

Bishana is a women's support group that was recently formed in May 2014. It was specifically established for all female cancer patients and survivors. Besides participating in educational, social, and recreational activities, Bishana provides a platform for these women to give and receive psychological and emotional support. Membership is free.

FIND OUT MORE

Reach to Recovery (RTR) was established in 1973 as a breast cancer support group to help women cope with life challenges brought about by a diagnosis of breast cancer. Members participate in activities ranging from educational talks or workshops, social and recreational events, outings, and enrichment programmes. Membership is free.

FIND OUT MORE

The Look Good Feel Better Programme was developed specifically for women undergoing chemotherapy or radiotherapy. The programme aims to help them minimise and manage the physical changes brought about by cancer treatment. Workshops organised are hands-on and held at various private and public hospitals island-wide. Membership is free.

FIND OUT MORE